CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Beginning balance at Dec. 31, 2024		$ 76	$ 421,528	$ (378,393)	$ 43,211
Beginning balance (in shares) at Dec. 31, 2024	[1]	75,850,275
Issuance of common stock under the Sales Agreement, net		$ 1	2,860		2,861
Issuance of common stock under the Sales Agreement, net (in shares)	[1]	1,325,179
Share-based compensation related to stock options			336		336
Share-based compensation related to restricted stock awards			204		204
Exercise of warrants and options		$ 1	2,214		2,215
Exercise of warrants and options (in shares)	[1]	958,375
Net Income (Loss)				(3,619)	(3,619)
Ending balance at Mar. 31, 2025		$ 78	427,142	(382,012)	45,208
Ending balance (in shares) at Mar. 31, 2025	[1]	78,133,829
Beginning balance at Dec. 31, 2025		$ 80	433,147	(384,997)	48,230
Beginning balance (in shares) at Dec. 31, 2025	[1]	80,425,981
Share-based compensation related to stock options			362		362
Share-based compensation related to restricted stock awards			170		170
Exercise of warrants and options		$ 1	149		150
Exercise of warrants and options (in shares)	[1]	145,661
Net Income (Loss)				18,317	18,317
Ending balance at Mar. 31, 2026		$ 81	$ 433,828	$ (366,680)	$ 67,229
Ending balance (in shares) at Mar. 31, 2026	[1]	80,571,642

[1] Common stock, $0.001 par value; Authorized – as of March 31, 2026 and December 31, 2025 – 185,000,000 shares.